Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Icatibant intra-articular dosing study in symptomatic knee osteoarthritis
2005-003258-87Phase 2Completed
- Sponsor
- Sanofi
- Start
- Jan 2006
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of icatibant in knee osteoarthritis (OA) (3 arms), sponsored by Sanofi. Primary endpoint: Baseline-corrected daily averaged VAS score for general knee pain. Started Jan 2006; status: completed.
02
Drugs
icatibant
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on 2005-003258-87.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-003258-87.